Kathleen E. Squires, M.D., Global Director of Scientific Affairs for HIV in Merck Research Labs
Kathleen E. Squires, MD joined the Global Center of Scientific Affairs in Merck Research Laboratories as the new Global Director of Scientific Affairs (GDSA) for HIV in August, 2017. Previously, she was the W. Paul and Ida H. Havens Professor of Infectious Diseases at the Sidney Kimmel Medical College of Thomas Jefferson University (TJU), Director of the Division of Infectious Diseases, Thomas Jefferson University Hospitals and Medical Director, Strategic Clinical Programs and Infectious Disease Population Health, Jefferson Enterprise. Dr. Squires graduated from Princeton University, completed medical school and an internal medicine residency at the Medical College of Pennsylvania and then pursued a fellowship in the Division of Infectious Diseases at the New York Hospital, Weill Cornell University Medical College. Before joining TJU in 2005, she was on the faculty of the University of Alabama at Birmingham and the University of Southern California where she was the Medical Director of the LAC/USC HIV Clinic and the PI of the USC ACTG CSU. She is board certified in Internal Medicine and Infectious Diseases. Her primary field of academic interest lies in the field of HIV infection and she has extensive experience in the treatment of HIV-infected patients as well as in clinical research. Major areas of interest within this field include identification of novel antiretroviral agents, development of novel treatments strategies, and HIV infection in women. Dr. Squires has been conducting HIV clinical trials for almost 30 years and has authored or co-authored over 120 articles on varied topics in the research and treatment of HIV/AIDS. She has provided peer review as a standing member on several NIH committees including the NIH Fogarty International Scholar Review Panel, as the Chairperson for the AIDS Clinical Studies and Epidemiology Study Section from 2008-2010 and a member of the Department of Health and Human Services Panel on the Treatment of HIV-infected Pregnant Women and Prevention of Peri-natal Transmission.